Quarterly report pursuant to Section 13 or 15(d)

Concentrations

v3.21.1
Concentrations
3 Months Ended
Mar. 31, 2021
Risks and Uncertainties [Abstract]  
Concentrations

Note 11 – Concentrations.

 

Sales

 

During the three months ended March 31, 2021, we had one significant customer, which accounted for 31% of sales.

 

Supplier

 

We also have a single source for our bioelectric medical devices, which account for 100% of our sales. The interruption of products provided by this supplier would adversely affect our business and financial condition unless an alternative source of products could be found.

  

Accounts Receivable

 

At March 31, 2021, we had one customer which accounted for 61% of our account receivable balances.